2 - A Comparative Effectiveness Trial of Extended-Release Medications with Individuals Leaving Jail: Lessons Learned

Tuesday, November 1, 2022

1:30 PM – 3:00 PM

Location: Johnson A-B, Level 1

CE: 1.5

Primary Presenter(s)

MG

Michael S. Gordon, DPA

Senior Research Scientist
Friends Research Institute
Baltimore, Maryland

Co-Presenter(s)

Marc Fishman, MD

Medical Director
Maryland Treatment Centers
Baltimore, Maryland
Mary Ann Thompson

Warden / President, Maryland Correctional Administrators Association
St. Mary's County Detention and Rehabilitation Center
Leonardtown, Maryland

Learning Objectives:

At the completion of this activity, participants will:

Describe the importance of conducting research on individuals with current and pre-incarceration opioid use disorder (OUD) histories nearing release from correctional settings.
List the potential benefits and challenges of introducing extended-release medications with individuals in jail.
Recall the unique challenges that jail administrators face when implementing MOUDs in their facilities.

Presentation Summary: Very few incarcerated individuals receive medications for OUD (MOUD), a treatment widely known to reduce the risks of opioid-related harms. Friends Research Institute was funded as a clinical hub on a 5-year grant from the National Institute on Drug Abuse (NIDA) under the Helping to End Addiction Long-term (HEAL) Justice Community opioid Innovation Network (JCOIN). The following workshop will discuss our experience implementing and initiating extended-release medications with individuals in multiple county jails in Maryland. The proposed workshop will discuss the unique challenges and importance involved in providing extended-release medications in jail and continuing upon release in the community.